Pulse Explorer nav.journalClub Débats Tendances Chercheurs Revues

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Accueil Explorer nav.journalClub Tendances

⌘+K

Revisiting the Use of β-Blockers in Hypertension: Time for Action | Synapse

March 31, 2026Hypertension1 citations

View Full Paper

Revisiting the Use of β-Blockers in Hypertension: Time for Action

RBRaffaele BugiardiniGeneral Cardiology ECEdina CenkoGeneral Cardiology MMM. Haisum MaqsoodHouston Methodist

Key Points

Key points are not available for this paper at this time.

Demander à l'IA

Like

Bookmark

Share

View Full Paper

Demander à l'IA

Like

Bookmark

Share

View Full Paper

Cite This Study

Bugiardini et al. (Wed,) studied this question.

synapsesocial.com/papers/6a025c81edf6f481385946e2 https://doi.org/https://doi.org/10.1161/hypertensionaha.125.26146

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol2002 · 5,428 citations
2Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis2019 · 392 citations
3Sex-Related Differences in Heart Failure After ST-Segment Elevation Myocardial Infarction2019 · 89 citations
4β blockers switched to first-line therapy in hypertension2023 · 45 citations
5Prior Beta-Blocker Therapy for Hypertension and Sex-Based Differences in Heart Failure Among Patients With Incident Coronary Heart Disease2020 · 29 citations